« Back to Record
Citation APA

Franzoi, M. A., Lambertini, M., Ceppi, M., Bruzzone, M., & de Azambuja, E. (2022). Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients. Breast cancer research and treatment. doi:10.1007/s10549-022-06525-3


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/340482

Franzoi, M. A., Lambertini, M., Ceppi, M., Bruzzone, M., & de Azambuja, E. (2022). Implication of body mass index (BMI) on the biological and clinical effects of endocrine therapy plus abemaciclib as neoadjuvant therapy for early breast cancer patients. Breast cancer research and treatment. doi:10.1007/s10549-022-06525-3